Vivos RDGL
OTC RDGL
$0.05 -0.01 (-16.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Vivos (RDGL) Total Debt (2010 - 2023)

Vivos (RDGL) posted Total Debt of $10000.0 for Q3 2023, down 99.68% sequentially from $3.1 million in Q1 2019.

Vivos (RDGL) Total Debt (2010 - 2023) Analysis & Trends

Vivos has reported Total Debt for 11 years, with the latest figure at $10000.0 in Q3 2023.

  • Quarterly Total Debt changed N/A year-over-year to $10000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $10000.0 (changed N/A YoY) and the FY2018 annual result came in at $3.1 million, changed N/A from the prior year.
  • Total Debt fell to $10000.0 in Q3 2023 per RDGL's latest filing, from $3.1 million in the prior quarter.
  • Over five years, Total Debt peaked at $3.1 million in Q1 2019 and troughed at $10000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 32.61 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 14.94 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 12.62 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 10.10 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 8.68 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 1.89 Bn
10 Vivos 24.08 Mn 22.53 Mn -3,105.00 -

Historic Data

Download Data
DateValue
Sep 30, 2023 10,000.00
Mar 31, 2019 3.14 Mn
Dec 31, 2018 3.14 Mn
Sep 30, 2018 32,279.00
Mar 31, 2018 40,000.00
Sep 30, 2017 383,771.00
Jun 30, 2017 383,771.00
Mar 31, 2017 383,771.00
Dec 31, 2016 332,195.00
Sep 30, 2016 332,195.00
Jun 30, 2016 332,195.00
Mar 31, 2016 1.33 Mn
Dec 31, 2015 1.28 Mn
Sep 30, 2015 1.06 Mn
Jun 30, 2015 4.53 Mn
Mar 31, 2015 935,806.00
Dec 31, 2014 4.46 Mn
Sep 30, 2014 512,094.00
Jun 30, 2014 583,429.00
Mar 31, 2014 349,913.00